|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
TFSL | Motta Anna Maria P | Former Chief Info. Officer | Apr 01 | Option Exercise | 0.00 | 14,700 | 0 | 106,240 | Apr 05 01:05 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Dec 10 | Option Exercise | 0.00 | 19,700 | 0 | 96,700 | Dec 14 02:51 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Nov 23 | Option Exercise | 15.08 | 5,000 | 75,400 | 77,000 | Nov 25 08:34 AM |
TFSL | Motta Anna Maria P | Chief Information Officer | Dec 10 | Option Exercise | 0.00 | 1,500 | 0 | 72,000 | Dec 12 04:32 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Dec 10 | Option Exercise | 0.00 | 13,000 | 0 | 70,500 | Dec 11 03:58 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Sep 05 | Option Exercise | 8.61 | 5,000 | 43,050 | 57,500 | Sep 07 12:13 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Mar 03 | Option Exercise | 8.61 | 10,000 | 86,100 | 59,190 | Mar 06 10:51 AM |
TFSL | Motta Anna Maria P | Chief Information Officer | May 20 | Option Exercise | 11.74 | 20,000 | 234,800 | 64,496 | May 23 02:02 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Mar 02 | Option Exercise | 11.74 | 20,000 | 234,800 | 60,283 | Mar 03 01:39 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Dec 15 | Option Exercise | 8.61 | 10,000 | 86,100 | 46,608 | Dec 17 01:39 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Aug 26 | Option Exercise | 11.74 | 10,000 | 117,400 | 44,631 | Aug 27 01:36 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Feb 19 | Option Exercise | 8.61 | 15,000 | 129,150 | 44,914 | Feb 20 02:36 PM |
TFSL | Motta Anna Maria P | Chief Information Officer | Dec 15 | Option Exercise | 0.00 | 20,000 | 0 | 36,484 | Dec 17 12:28 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite